在临床试验中评估新兴传染病治疗效果的策略
Kentaro Sakamaki1, Yukari Uemura2, Yosuke Shimizu2
1Faculty of Health Data Science, Juntendo University, Chiba, Japan; Center for Next Generation of Community Health, Chiba University Hospital, Chiba, Japan.
Contemporary clinical trials
|August 7, 2025
概括
对于新出现的传染病,建议在药物开发中使用总人口中的优先复合或多个终点. 在初级评估中,分层分析可能比非分层分析具有更大的力量.
科学领域:
- 临床试验的设计
- 药物监督 药物监督 药物监督
- 流行病学 流行病学
背景情况:
- 在疫情爆发期间优化治疗干预批准至关重要.
- 异质治疗效应使临床试验设计和终点选择复杂化.
- 具有不同治疗效果的优先组合终点的表现需要调查.
研究的目的:
- 通过模拟来评估新兴传染病的试验设计策略.
- 评估人群和终点选择对证明治疗疗效的影响.
- 在异质治疗效应下研究单个,多个和优先级组合终点的性能.
主要方法:
- 使用基于ACTT-1研究的多状态模型模拟的临床试验数据.
- 检查了人口 (总和子组) 和终点策略的八种组合.
- 考虑了八种治疗效果场景,包括因疾病严重程度而异质的场景.
主要成果:
- 在非异质情景中,总体人口分析显示出比子组分析更高的功率.
- 恢复时间显示出高功率;复合和多个终点是可比的.
- 在异质场景中,小组分析和优先考虑的复合终点显示,当治疗效果不同时,功率增加.
结论:
- 优先考虑新兴传染病中药物开发的总人口中的复合或多个终点.
- 分层分析可能比非分层分析更强大,因此应考虑初级分析.
- 试验设计应根据疾病严重程度考虑治疗效果的潜在异质性.
相关概念视频
Clinical Trials
8.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.4K
Study Designs in Epidemiology
419
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
419
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Strategies for Assessing and Addressing Confounding
155
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
155
Antimicrobial Effectiveness
159
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
159


